Connect with us

Hi, what are you looking for?

Jewish Business News

Health

New Cheap Covid-19 Vaccine Corbevax Could Save the World

Corbevax could be the answer to Covid-19.

COVID19

COVID19 vaccine for kids/ photo MDA

A new Covid-19 vaccine cold Corbevax could just be an answer to the world’s prayers. Developed by scientists at from the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine, the new Covid-19 vaccine is patent free and so would be really cheap to acquire for the billions of people all over the world.

The new vaccine has already been approved in India for emergency use for Covid-19.

So, how does this new Coronavirus vaccination work? Dubbed “The World’s COVID-19 Vaccine”, Corbevax uses a traditional recombinant protein-based technology that will enable its production at large scales making it widely accessible to inoculate the global population. The initial construct and production process of the vaccine antigen was developed at Texas Children’s Hospital CVD, led by Co-directors Drs. Maria Elena Bottazzi and Peter Hotez and in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialization team, to Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE).

Clinical trials involving more than 3000 subjects found Corbevax to be safe, well tolerated and immunogenic. As for the Delta Starin, the new Covid-19 vaccination was found to 80 percent effective for the prevention of symptomatic infections based on published studies.


“Protein-based vaccines have been widely used to prevent many other diseases, have proven safety records, and use economies of scale to achieve low-cost scalability across the world,” said Dr. Maria Elena Bottazzi, Professor and Associate Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children’s Hospital Center for Vaccine Development. “Our decade-long studies advancing coronavirus vaccine prototypes has led to the creation of this vaccine, which will fill the access gap created by the more expensive, newer vaccine technologies and that today are still not able to be quickly scaled for global production.”

“This announcement is an important first step in vaccinating the world and halting the pandemic. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant,” said Dr. Peter Hotez, Professor and Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children’s Hospital Center for Vaccine Development. “Widespread and global vaccination with our Texas Children’s-Baylor-BE vaccine would also forestall the emergence of new variants. We have previously missed that opportunity for the alpha and delta variant. Now is our chance to prevent a new global wave from what might follow.”

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.